HIRSCHMAN ORIN 13D/13G Filings for NLS Pharmaceutics AG (NLSP)

HIRSCHMAN ORIN 13D and 13G filings for NLS Pharmaceutics AG:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-03-17
4:10 pm
Sale		 2021-03-12 13G NLS Pharmaceutics AG
NLSP		 HIRSCHMAN ORIN 14,430
4.900%		 -8,570decrease
(-37.26%)		 Filing
2021-02-04
06:30 am
Purchase		 2021-01-29 13G NLS Pharmaceutics AG
NLSP		 HIRSCHMAN ORIN 23,000
7.800%		 23,000increase
(New Position)		 Filing